Jeff Holford is a Senior Analyst at T. Rowe Price, specializing in the pharmaceutical sector. With over 15 years of experience in equity research, Jeff has a deep understanding of the complexities and opportunities within the healthcare industry. His expertise includes evaluating the risk/reward profiles of large-cap pharmaceutical companies and identifying key trends and innovations that shape the sector. Jeff's analytical rigor and strategic insights have made him a trusted voice in the field. He holds a Ph.D. in Pharmacology and a Bachelor's degree in Biochemistry, bringing a strong scientific background to his financial analysis. Jeff is committed to providing thorough and actionable research to support informed investment decisions.